AMC — what changed in the latest 10-Q
A section-by-section comparison of AMC's newest periodic SEC filing (10-K/10-Q) against the prior same-form filing: paragraphs added and removed per section, with verbatim excerpts. Purely a deterministic text diff — no similarity scores, no directional read, not investment advice.
Comparing 10-Q · 2026-11-04 vs the prior 10-Q · 2026-07-23
| Section | Outcome | Added | Removed | Minor | Unchanged |
|---|---|---|---|---|---|
| MD&A | Text added/removed | +115 | −144 | ~40 | 63 |
| Market risk (Item 3) | Text added/removed | +10 | −7 | ~5 | 1 |
| Controls & procedures | Text added/removed | 0 | 0 | ~2 | 0 |
| Legal proceedings | Text added/removed | +1 | −5 | 0 | 1 |
| Risk factors | Some risk factors updated | +6 | −4 | ~6 | 24 |
| Other information | Text added/removed | +4 | 0 | ~1 | 0 |
Counts are paragraphs; added/removed means text added or removed vs the prior filing — no direction or judgement implied.
Representative excerpts
Up to 5 excerpts of about 300 characters per section, quoted verbatim from the two SEC filings.
MD&A
Text added vs the prior filing · source: 10-Q · 2026-11-04
●the risks and uncertainties relating to refinancing transactions, including, but not limited to, (i) the potential for additional future dilution of our Common Stock as a result of issuance of shares underlying the Existing Exchangeable Notes or other convertible or exchangeable debt we may issue a…
●changing practices of distributors, including increased use of alternative film delivery methods including streaming platforms and premium video on demand, shrinking exclusive theatrical release windows or release of movies to theatrical exhibition and streaming platforms on the same date, the thea…
●the risk that the North American and international box office will not achieve sustained recovery, resulting in continued cash burn and the need to seek additional financing, which may not be available at favorable terms, or at all;
Significant Events—For the Nine Months Ended September 30, 2026
2026 Refinancing Transactions. On October 5, 2026, we completed the 2026 Refinancing Transactions, which included issuing $2,000.0 million aggregate principal amount of 8.875% first lien notes, $850.0 million aggregate principal amount of first lien term loans, $1,120.0 million aggregate principal a…
Text removed vs the prior filing · source: 10-Q · 2026-07-23
●the risks and uncertainties relating to the 2025 Refinancing Transactions and 2024 Refinancing Transactions (each defined herein), including, but not limited to, (i) the potential for additional future dilution of our Common Stock as a result of issuance of shares underlying our Existing Exchangeab…
of any litigation or claims of default that might arise in connection with the 2025 Refinancing Transactions or 2024 Refinancing Transactions;
●changing practices of distributors, which accelerated during the COVID-19 pandemic, including increased use of alternative film delivery methods including premium video on demand, streaming platforms, shrinking exclusive theatrical release windows or release of movies to theatrical exhibition and s…
●the risk that the North American and international box office in the near term will not recover sufficiently, resulting in continued cash burn and the need to seek additional financing, which may not be available at favorable terms, or at all;
Odeon Credit Agreement. On April 17, 2026, Odeon Finco, a wholly-owned direct subsidiary of OCGL and an indirect subsidiary of Holdings, entered into the Odeon Credit Agreement, by and among Odeon Finco, as borrower, OCGL, as the company, the lenders party thereto and U.S. Bank Trust Company, Nation…
Market risk (Item 3)
Text added vs the prior filing · source: 10-Q · 2026-11-04
On October 5, 2026, we repaid all of the outstanding Muvico Term Loans and borrowed $850.0 million aggregate principal amount of New 1L Term Loans as part of the 2026 Refinancing Transactions. The New 1L Term Loans bear interest at the Company’s election, at either (i) the Alternate Base Rate (as de…
Market risk on performance-based variable-rate financial instruments. As of September 30, 2026, we had an aggregate of $903.4 million outstanding principal amount of the New 2029 Notes which bear interest ranging from 11.5% to 15.0% per annum depending on the Total Leverage Ratio. The rate in effect…
A 100-basis point change in market interest rates would have caused an increase (decrease) in the fair value of our performance-based variable-rate financial instruments of approximately $21.8 million and $(21.2) million, respectively, as of September 30, 2026.
On October 5, 2026, in connection with the 2026 Refinancing Transactions, the New 2029 Notes were redeemed in full and the New 2029 Notes Indenture was satisfied and discharged, As a result, following the 2026 Refinancing Transactions, we no longer have any performance-based variable-rate financial …
Market risk on fixed-rate financial instruments. Included in corporate borrowings as of September 30, 2026, were principal amounts of $116.1 million of the Existing Exchangeable Notes, $360.0 million of the Existing 7.5% Notes, and $423.9 million of the Odeon Term Loans due 2031. A 100-basis point c…
Text removed vs the prior filing · source: 10-Q · 2026-07-23
Market risk on performance-based variable-rate financial instruments. As of June 30, 2026, we had an aggregate of $903.4 million outstanding principal amount of our New 2029 Notes which bear interest ranging from 11.5% to 15.0% per annum depending on the Total Leverage Ratio. The rate in effect for …
A 100-basis point change in market interest rates would have caused an increase (decrease) in the fair value of our performance-based variable-rate financial instruments of approximately $21.6 million and $(21.0) million, respectively, as of June 30, 2026.
Market risk on fixed-rate financial instruments. Included in corporate borrowings as of June 30, 2026, were principal amounts of $116.1 million of our Existing Exchangeable Notes, $360.0 million of our Existing 7.5% Notes, $425.0 million of our Odeon Term Loans due 2031, and $125.5 million of our Se…
Included in corporate borrowings as of June 30, 2025, were principal amounts of $444.7 million of our Existing Exchangeable Notes, $950.0 million of our Existing 7.5% Notes, $131.2 million of our Second Lien Notes, $400.0 million of our Odeon Notes due 2027, $41.9 million of our Senior Subordinated …
Foreign currency exchange rate risk. We are also exposed to market risk arising from changes in foreign currency exchange rates affecting our International markets operations. International markets revenues and operating
Legal proceedings
Text added vs the prior filing · source: 10-Q · 2026-11-04
On October 31, 2025, a purported securities class action captioned Simons v. AMC Entertainment Holdings, Inc., No. 1:25-cv-09042-JLR, was filed by a purported former holder of AMC Preferred Equity Units against the Company in the United States District Court for the Southern District of New York. Th…
Text removed vs the prior filing · source: 10-Q · 2026-07-23
On May 4, 2023, the Company filed a lawsuit in the Superior Court of the State of Delaware against seventeen insurers participating in its directors & officers insurance program, seeking recovery for losses incurred in connection with its defense and settlement of In re AMC Entertainment Holdings, I…
The remaining insurer contested whether it owed coverage for the settlement payment, claiming it does not constitute a “Loss” under its insurance policy (the “Loss Defense”). On February 28, 2025, the court denied a motion for summary judgment by the remaining insurer in the Coverage Action, and gra…
Court’s decision in favor of the Company. Shortly thereafter, the remaining insurer paid the Company its full limits, plus pre- and post-judgment interest and the case was closed.
AMC also had claims for coverage from additional insurers, however, those insurers’ policies contain mandatory arbitration provisions, so they were not included in the Coverage Action. On January 24, 2025, the Company sent a notice of arbitration to the four remaining insurers with mandatory arbitra…
On October 31, 2025, a purported securities class action captioned Simons v. AMC Entertainment Holdings, Inc., No. 1:25-cv-09042-JLR, was filed by a purported former holder of AMC Preferred Equity Units against the Company in the United States District Court for the Southern District of New York. Th…
Risk factors
Text added vs the prior filing · source: 10-Q · 2026-11-04
Common Stock. In May 2026, we exchanged 142.1 million shares of Common Stock for the New Exchangeable Notes, including accrued and unpaid interest, representing the exchange in full of the New Exchangeable Notes for shares of Common Stock.
As of November 3, 2026, there were 892,604,638 shares of Common Stock issued and outstanding. In addition, as described above, shares of Common Stock may be used to settle exchanges of the Existing Exchangeable Notes, including any additional Existing Exchangeable Notes or interest paid in-kind by i…
As of November 3, 2026, we had approximately 143,258,701 authorized shares of Common Stock that have not been issued or reserved for issuance in connection with our employee plans or exchanges under the Existing Exchangeable Notes. As a result, we may in the future seek to obtain the requisite stock…
investors purchase at inflated prices unrelated to our financial performance or prospects, and may thereafter suffer substantial losses as prices decline once the level of short-covering purchases has abated; and
On September 24, 2026, the Company’s stockholders approved the First Amendment to the Company’s 2024 Equity Incentive Plan (as amended, the “Equity Incentive Plan”), which increased the number of shares of Common Stock available for issuance under the Equity Incentive Plan from 25,000,000 to 50,000,…
Text removed vs the prior filing · source: 10-Q · 2026-07-23
As of July 22, 2026, there were 892,604,638 shares of Common Stock issued and outstanding. In addition, as described above, shares of Common Stock may be used to settle exchanges of the Existing Exchangeable Notes, including any additional Existing Exchangeable Notes or interest paid in-kind by issu…
As of July 22, 2026, we had approximately 168,258,701 authorized shares of Common Stock that have not been issued or reserved for issuance in connection with our employee plans or exchanges under the Existing Exchangeable Notes. As a result, we may in the future seek to obtain the requisite stockhol…
•ongoing impacts upon the industry resulting from the COVID-19 pandemic;
The current equity incentive plan of the Company has insufficient available shares to make additional grants at historic levels. As required by NYSE rules, the Company intends to ask its stockholders for approval to allocate additional shares to the plan at its 2026 annual meeting. There can be no g…
Other information
Text added vs the prior filing · source: 10-Q · 2026-11-04
On September 28, 2026, Daniel E. Ellis, Executive Vice President, Chief Operations, Development and Marketing Officer of the Company, adopted a Rule 10b5-1 trading arrangement that is intended to satisfy the affirmative defense of Rule 10b5-1(c) for the purchase of shares of the Company’s Common Sto…
The Company plans to hold its 2027 Annual Meeting of Stockholders (the “2027 Annual Meeting”) on June 10, 2027. The time and location of the 2027 Annual Meeting will be specified in the 2027 proxy statement. Because the 2027 Annual Meeting will be more than thirty (30) days prior to the anniversary …
Additionally, in accordance with the advance notice provisions set forth in the Company’s Bylaws, in order for a stockholder proposal submitted outside of Rule 14a-8 or a director nomination submitted by a stockholder to be considered timely, it must be received by the Corporate Secretary not earlie…
Company’s nominees must provide notice that sets forth the information required by Rule 14a-19 under the Exchange Act no later than April 11, 2027.
How to read Risk Factors (Item 1A) in a 10-Q
A 10-Q risk-factor section usually takes one of three forms; this page classifies it as one of:
- Pointer — the filer states there have been no material changes and points back to the annual 10-K risk factors; there is no own risk text to compare this quarter.
- Partial update — the filer carves out specific updated risks ("except as set forth below"); the excerpts show exactly what is new this quarter.
- Restated in full — the quarter carries the complete risk-factor text. When the prior quarter was only a pointer there is no prior full text to diff against, so the page flags the section as restated instead.
This describes the filing structure only — it is never a judgement on whether risk went up or down.
Source: text-level diff of the two SEC EDGAR filings · deterministic (no AI-generated content) · for reference only · not investment advice